Delivery Order SPE2DB25D3006-SPE2DB25FXJQE
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $16,762.09 to AmerisourceBergen Drug Corp for AIRSUPRA 90-80 MCG Inhaler 10.7GM pharmaceutical supplies. This firm fixed price, non-set-aside contract was awarded on September 11, 2025, with an ultimate completion date of September 12, 2025, and will be performed in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills this order as...
- The Defense Logistics Agency awarded a $1,476.23 firm fixed-price delivery order to AmerisourceBergen Drug Corp for AIRSUPRA 90-80 MCG inhalers (10.7GM) on September 4, 2025, with an ultimate completion date of September 5, 2025. This non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The performance location is...
- The Defense Logistics Agency awarded a $7,652.36 delivery order to AmerisourceBergen Drug Corp for AIRSUPRA 90-80 MCG Inhaler 10.7GM, a pharmaceutical product supporting federal medical supply needs. This non-set-aside, competitively awarded contract reflects a firm fixed price delivery order with an ultimate completion date of September 4, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,376.37 to AmerisourceBergen Drug Corp for AIRSUPRA 90-80 MCG Inhaler 10.7GM pharmaceutical product. This competitively awarded, firm fixed price delivery order was issued on August 14, 2025, with an ultimate completion date of August 15, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,867.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for AIRSUPRA 90-80 mcg inhaler (10.7 gm) on May 30, 2025, with an ultimate completion date of June 2, 2025. This non-competitive delivery order was placed against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The work will be performed at the company's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $7,062.30 to AmerisourceBergen Drug Corp for AIRSUPRA 90-80 MCG inhaler 10.7GM on April 21, 2025, with completion targeted for April 22, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical supply will...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,746.06 to AmerisourceBergen Drug Corp on May 29, 2025, for the supply of Airsupra 90-80 mcg inhaler in a 10.7-gram formulation. This firm fixed-price, non-competitive delivery order is expected to be completed by May 30, 2025, with fulfillment occurring at the vendor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $1,828.45 to AmerisourceBergen Drug Corp for AIRSUPRA 90-80 MCG Inhaler 10.7GM pharmaceutical products. The contract is a firm fixed price delivery order with an ultimate completion date of July 21, 2025, and was awarded on July 18, 2025. No set-aside designation was used in this competitive award. Performance will take place in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency awarded a $2,560.18 firm fixed price delivery order to AmerisourceBergen Drug Corp for AIRSUPRA 90-80 MCG inhaler 10.7GM, with an ultimate completion date of August 6, 2025. This non-set-aside contract represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order will be fulfilled from the contractor's corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,696.72 to AmerisourceBergen Drug Corp for AIRSUPRA 90-80 MCG Inhaler 10.7GM pharmaceutical products. This firm fixed-price, non-set-aside delivery order was awarded on July 24, 2025, with an ultimate completion date of July 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- SPE2DB25D3006Indefinite Delivery Contract
- SPE2DB25D3006-SPE2DB25FXJQEDelivery Order
The Defense Logistics Agency awarded a $14,008.25 firm fixed-price delivery order to AmerisourceBergen Drug Corp for AIRSUPRA 90-80 MCG inhaler 10.7GM pharmaceutical supplies. This non-set-aside contract was awarded on June 25, 2025, with an ultimate completion date of June 26, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was competitively selected to fulfill this medical supply requirement supporting federal healthcare needs. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The prime IDV serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. Through this contract structure, AmerisourceBergen Drug Corp provides critical medical commodities to customers including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, positioning the company as a key vendor in the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.0k | 6/25/25 |